Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: QS21|BIOLOGICAL: sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine|OTHER: immunoenzyme technique|OTHER: immunologic technique|OTHER: laboratory biomarker analysis
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI)